JJ
James A Johnson

James A Johnson insider trades: Athira Pharma (ATHA) stock buys and sales

Athira Pharma Last trade Mar 29, 2023 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2005
4
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 29, 2023ATHA↑ Buy$12K
Nov 11, 2016NSTG↓ Sell$226K
Sep 8, 2010ZGEN↓ Sell$195K
Dec 7, 2009ZGEN↓ Sell$70K
Aug 31, 2009ZGEN↓ Sell$60K
Aug 24, 2006ZGEN↓ Sell$60K
Mar 13, 2006ZGEN↓ Sell$65K
Jan 12, 2006ZGEN↓ Sell$227K
Jan 9, 2006ZGEN↓ Sell$60K
Jan 5, 2006ZGEN↓ Sell$54K
May 17, 2005ZGEN↓ Sell$54K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ATHA insiders

Open-market trades in the last 12 months

About James A Johnson's insider trades

James A Johnson is an insider at Athira Pharma (ATHA). Since May 17, 2005, James has reported 1 open-market purchase worth $12K and 10 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (28 filings), option exercises (6 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATHA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.